Ditropan XL Patent Invalid; J&J Petition Last Obstacle To ANDA Approvals
Executive Summary
A Johnson & Johnson citizen petition appears to be the only impediment to approval of generic versions of Ditropan XL after a patent for the incontinence therapy was deemed invalid
You may also be interested in...
FDA Approves Generic Of GSK Flonase But Launch Halted By Restraining Order
FDA's approval of generic Flonase has prompted a lawsuit by GlaxoSmithKline representing another challenge by brand manufacturers to the legitimacy of FDA-approved generic drugs
FDA Approves Generic Of GSK Flonase But Launch Halted By Restraining Order
FDA's approval of generic Flonase has prompted a lawsuit by GlaxoSmithKline representing another challenge by brand manufacturers to the legitimacy of FDA-approved generic drugs
Citizen Petition Reform Proposals Include User Fees, Payments For Lost Profits
User fees for citizen petitions may discourage abuse of the process, Sandoz VP-Intellectual Property & Regulatory Shashank Upadhye said Sept. 30 at the Institute for International Research's Annual Generic Drugs Summit in Washington, D.C